ArticleHealthcare (Basel, Switzerland)2022
IoT Based Expert System for Diabetes Diagnosis and Insulin Dosage Calculation.
Article in Healthcare (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- The Unfinished Ecosystem: Why Remote Patient Monitoring Has Matured Unevenly, and What Closing the Gap Will Require.Healthcare (Basel, Switzerland) · 2026Article
- Portable Infrared-Based Glucometer Reinforced with Fuzzy Logic.Biosensors · 2023Article
- Optimized type-2 fuzzy controller based on IoMT for stabilizing the glucose level in type-1 diabetic patients.Scientific reports · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
High blood glucose levels are the defining characteristic of diabetes. Uncontrolled blood glucose levels in diabetic patients might result in mortality. As a result, there is a dire need to control blood glucose levels by constantly monitoring them and delivering the appropriate amount of insulin. However, insulin consumption is affected by several variables, including age, calorific intake, and body weight. The patient must see the doctor on a regular basis in order to determine the appropriate dose. Nonetheless, hospital facilities are finding it increasingly difficult to treat patients as the number of patients rises; thus, the healthcare industry is searching for an efficient method that can alleviate their burden by assisting patients with chronic conditions through remote patient care. In this work, we have developed an expert system to provide remote treatment for diabetic patients. Our expert system consists of two distinct components: one for the patient and one for the hospital. The sole requirement for the patient will be a wearable device that captures and transmits all relevant data to the cloud. On the hospital side, there should be a system in place to process that data in the cloud. The system employs a fuzzy system to handle data in two stages. A fuzzy system is initially employed to identify whether or not a patient is diabetic. In the second stage, a fuzzy system is utilized to determine the insulin dosage for a diabetic patient. Using sensors and the ESP8266 platform, we have developed a prototype of patient-side hardware. The MATLAB fuzzy toolbox is used for the processing part, which includes fuzzy systems, and the results of the MATLAB analysis are presented in the form of simulation results to demonstrate the accuracy of the proposed system in terms of determining insulin dosage. The results of the simulation using the fuzzy toolbox for the insulin dose of the diabetic patient are significantly close to the amount of dosage prescribed by the endocrinologist.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.